17-[5-(1-Hydroxy-2-methoxy-2-methyl-propyl)-2-methoxy-tetrahydro-furan-3-yl]-4,4,10,13,14-pentamethyl-1,2,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one 21alpha,25-Dimethylmelianodiol 9,19-cyclolanostan-28-oic acid, 3,7,16-trihydroxy-24-methylene-, (3beta,5xi,7beta,8xi,9xi,10xi,16beta,17xi,20xi)- InChI=1/C32H52O5/c1-28(2)24-11-10-22-21(30(24,5)15-14-25(28)33)13-17-31(6)20(12-16-32(22,31)7)19-18-23(37-27(19)35-8)26(34)29(3,4)36-9/h10,19-21,23-24,26-27,34H,11-18H2,1-9H3/t19-,20-,21?,23?,24?,26?,27+,30+,31-,32+/m0/s rel-(10R,13S,14S,17S)-17-[(2R,3S)-5-(1-hydroxy-2-methoxy-2-methylpropyl)-2-methoxytetrahydrofuran-3-yl]-4,4,10,13,14-pentamethyl-1,2,4,5,6,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phen